GSK enquiries
| |||
Media:
|
Tim Foley
|
+44 (0) 20 8047 5502
|
(London)
|
Dan Smith
|
+44 (0) 20 8047 5502
|
(London)
| |
Kathleen Quinn
|
+1 202 603 5003
|
(Washington DC)
| |
Lyndsay Meyer
|
+1 202 302 4595
|
(Washington DC)
| |
Investor Relations:
|
Nick Stone
|
+44 (0) 7717 618834
|
(London)
|
James Dodwell
|
+44 (0) 20 8047 2406
|
(London)
| |
Mick Readey
|
+44 (0) 7990 339653
|
(London)
| |
Josh Williams
|
+44 (0) 7385 415719
|
(London)
| |
Camilla Campbell
|
+44 (0) 7803 050238
|
(London)
| |
Steph Mountifield
|
+44 (0) 7796 707505
|
(London)
| |
Jeff McLaughlin
|
+1 215 751 7002
|
(Philadelphia)
| |
Frannie DeFranco
|
+1 215 751 4855
|
(Philadelphia)
|
GSK plc
| |
(Registrant)
| |
Date: June 28, 2024
| |
By:/s/ VICTORIA WHYTE
--------------------------
| |
Victoria Whyte
| |
Authorised Signatory for and on
| |
behalf of GSK plc
|
Attachments
- Original Link
- Permalink
Disclaimer
GSK plc published this content on 28 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 June 2024 17:21:44 UTC.